Who owns Legend Biotech Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LEGN from SEC Form 13F filings across 197 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 197 institutions disclosed 100.5M shares of Legend Biotech Corp worth $2.00B — about 54.5% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
197
13F holders
$2.00B
value, 2026 filers
54.5%
of shares outstanding (100.5M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of LEGN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 24.2M | $481.3M | 0.0% | 13.1% | -16.8% |
| 2 | Kynam Capital Management, LP | 9.2M | $182.1M | 10.1% | 5% | +205.0% |
| 3 | HHLR ADVISORS, LTD. | 8.4M | $166.3M | 10.8% | 4.5% | +39.7% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 8.1M | $161.9M | 2.5% | 4.4% | 0.0% |
| 5 | MONTANOVA CAPITAL, LLC | 6.2M | $123.9M | 2.9% | 3.4% | -11.9% |
| 6 | WESTFIELD CAPITAL MANAGEMENT CO LP | 5.2M | $102.4M | 0.3% | 2.8% | +16.3% |
| 7 | BlackRock, Inc. | 5.1M | $101.3M | 0.0% | 2.8% | +7.8% |
| 8 | STATE STREET CORP | 1.6M | $32.2M | 0.0% | 0.9% | +8.1% |
| 9 | Point72 Asset Management, L.P. | 1.6M | $31.9M | 0.0% | 0.9% | -47.8% |
| 10 | Elmind Capital, LP | 1.6M | $31.2M | 7.7% | 0.9% | +175.1% |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.5M | $30.3M | 0.0% | 0.8% | +828.7% |
| 12 | MORGAN STANLEY | 1.5M | $30.1M | 0.0% | 0.8% | +8.6% |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 1.2M | $24.4M | 0.0% | 0.7% | +22.7% |
| 14 | AIHC Capital Management LtdNEW | 1.2M | $23.5M | 21.6% | 0.6% | new |
| 15 | Balyasny Asset Management L.P. | 1.2M | $23.4M | 0.0% | 0.6% | +458.3% |
| 16 | Soleus Capital Management, L.P. | 1.1M | $21.6M | 0.8% | 0.6% | -9.9% |
| 17 | Ghisallo Capital Management LLC | 1.0M | $19.9M | 0.4% | 0.5% | 0.0% |
| 18 | Triata Capital Ltd | 989,014 | $19.7M | 3.7% | 0.5% | +57.0% |
| 19 | MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 914,794 | $18.2M | 7.6% | 0.5% | -0.3% |
| 20 | JPMORGAN CHASE & CO | 850,663 | $16.0M | 0.0% | 0.5% | +11.0% |
| 21 | Davern Capital Partners, LP | 828,880 | $16.5M | 3.2% | 0.4% | -30.4% |
| 22 | JOHNSON & JOHNSON | 814,586 | $16.2M | 2.1% | 0.4% | 0.0% |
| 23 | ACADIAN ASSET MANAGEMENT LLC | 795,716 | $15.8M | 0.0% | 0.4% | +2682.6% |
| 24 | IvyRock Asset Management (HK) Ltd | 770,200 | $15.3M | 8.1% | 0.4% | -3.8% |
| 25 | GOLDMAN SACHS GROUP INC | 724,470 | $14.4M | 0.0% | 0.4% | -80.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.